Active, not recruitingPhase 4NCT06436274

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Ruanne Barnabas, MBChB, MSc, DPhil
Massachusetts General Hospital
Intervention
GARDASIL®9(biological)
Enrollment
778 enrolled
Eligibility
16 years · FEMALE
Timeline
20242027

Study locations (3)

Collaborators

University of Witwatersrand, South Africa · Botswana Harvard Health Partnership · Ministry of Health, Rwanda · Fred Hutchinson Cancer Center · National Cancer Institute (NCI) · Karolinska Institutet

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06436274 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials